Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy
Michael Y. Zhang(Fred Hutch Cancer Center), Akiko Shimamura(Harvard University), Jane E. Churpek(University of Wisconsin–Madison), Marshall S. Horwitz(University of Washington), Inga Hofmann(Dana-Farber Cancer Institute), Scott A. Coats(Fred Hutch Cancer Center), Süleyman Gülsüner(University of Washington Medical Center), Melissa Forouhar(Madigan Army Medical Center), Jeffrey J. Delrow(Fred Hutch Cancer Center), Rafael Márquez, Mary‐Claire King(University of Washington), Janis L. Abkowitz(University of Washington), David A. Williams(Boston Children's Hospital), Lucy A. Godley(University of Chicago), Keith R. Loeb(Fred Hutch Cancer Center), Christopher J. Mariani(University of Chicago), Boglarka Gyurkocza(Cornell University), Marilyn Sánchez-Bonilla(Fred Hutch Cancer Center), R. Coleman Lindsley(Harvard University), Ming K. Lee(University of Washington Medical Center), Tom Walsh(University of Washington), Sioḃán Keel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bradford S. Schwartz(University of Wisconsin–Madison), Ryan Basom(Fred Hutch Cancer Center), Colin C. Pritchard(University of Washington), Barbara Neistadt(University of Chicago)
Cited by 367
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
|Pharmacological Reviews|2010|857